Skin Cancer Home > Erivedge and Breastfeeding
No studies have been done to determine whether Erivedge (vismodegib) passes through breast milk. Because of the unknown risks, the manufacturer recommends that women not take Erivedge while breastfeeding. If you decide to use this medicine while nursing, watch for any problems in your child, such as vomiting, diarrhea, or difficulty feeding.
Can Breastfeeding Women Take Erivedge?Erivedge™ (vismodegib) is a prescription medication used to treat people who have a type of skin cancer known as basal cell carcinoma. At this time, it is unknown whether Erivedge passes through breast milk. The manufacturer of the medication recommends that women not breastfeed during treatment.
More Information About Erivedge and BreastfeedingErivedge has not been studied during breastfeeding. Therefore, it is unknown whether the medicine passes through breast milk. Although this lack of information is certainly frustrating, it is important to remember that medications are rarely studied in breastfeeding women because doing so would expose an infant, who would otherwise not benefit from the medication, to potential harm.
Because so little is known at this point about Erivedge and breastfeeding, it may be safest to avoid breastfeeding while you are taking the drug. Many medicines are passed into breast milk, and it is possible that this one could be passed to your nursing child in some amount.
If your healthcare provider recommends taking Erivedge while breastfeeding, be sure to watch your child closely for any possible Erivedge side effects. Tell your child's healthcare provider if something does not seem right, or if you notice any side effects in your child, such as:
- Diarrhea or constipation
- Muscles spasms or tremors
- Unusual tiredness
- Lack of appetite or difficulty feeding.